Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OSELTAMIVIR HEC PHARM 30 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/OSELTAMIVIR HEC PHARM 30 MG CAPSULAS DURAS EFG

Approved

STANDARD

OSELTAMIVIR HEC PHARM 30 MG CAPSULAS DURAS EFG

Hec Pharm Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 24, 2020
Approval ID: fe26f8a8e7cdb06b
Company: Hec Pharm Gmbh
Type: Standard

Approval Details

Approval Id: fe26f8a8e7cdb06b
Drug Cima Aemps Name: OSELTAMIVIR HEC PHARM 30 MG CAPSULAS DURAS EFG
Register Number: 85275
Holder Company Name: Hec Pharm Gmbh
Marketing Company Name: Hec Pharm Gmbh
Authorization Date: 2020-07-24
Dosage Form: CÁPSULA DURA
Dose: 30 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Hec Pharm Gmbh

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 24, 2020

Approval ID

fe26f8a8e7cdb06b

Type

Standard

Back to CIMA-AEMPS Approvals